LTR Pharma has been named “APAC’s Top Clinical Stage Biopharmaceutical Company” and featured in a cover story by global life sciences publication, Life Sciences Review .
Featuring Executive Chairman Lee Rodne, the article highlights the Companyโs vision of enhancing menโs health and wellbeing by reimagining the treatment landscape for men with Erectile Dysfunction (ED) with its nasal spray SPONTAN, and restoring spontaneity to their intimate relationships.
Hereโs an excerpt:
โ๐๐ถ๐ด๐ต๐ณ๐ข๐ญ๐ช๐ข๐ฏ ๐ฅ๐ฐ๐ค๐ต๐ฐ๐ณ๐ด ๐ข๐ณ๐ฆ ๐ช๐ฏ๐ค๐ณ๐ฆ๐ข๐ด๐ช๐ฏ๐จ๐ญ๐บ ๐จ๐ข๐ช๐ฏ๐ช๐ฏ๐จ ๐ฑ๐ฐ๐ด๐ช๐ต๐ช๐ท๐ฆ ๐ณ๐ฆ๐ข๐ญ-๐ธ๐ฐ๐ณ๐ญ๐ฅ ๐ค๐ญ๐ช๐ฏ๐ช๐ค๐ข๐ญ ๐ถ๐ด๐ฆ ๐ข๐ฏ๐ฅ ๐ณ๐ฆ๐ค๐ฐ๐ฎ๐ฎ๐ฆ๐ฏ๐ฅ๐ช๐ฏ๐จ ๐ต๐ฉ๐ฆ ๐ฎ๐ฆ๐ฅ๐ช๐ค๐ข๐ต๐ช๐ฐ๐ฏ ๐ฃ๐ฆ๐ค๐ข๐ถ๐ด๐ฆ ๐ฐ๐ง ๐ช๐ต๐ด ๐ค๐ฐ๐ฏ๐ด๐ช๐ด๐ต๐ฆ๐ฏ๐ต ๐ฐ๐ถ๐ต๐ค๐ฐ๐ฎ๐ฆ๐ด ๐ฐ๐ท๐ฆ๐ณ ๐ต๐ณ๐ข๐ฅ๐ช๐ต๐ช๐ฐ๐ฏ๐ข๐ญ ๐๐ ๐ฎ๐ฆ๐ฅ๐ช๐ค๐ข๐ต๐ช๐ฐ๐ฏ๐ด. ๐๐๐ ๐๐ฉ๐ข๐ณ๐ฎ๐ข ๐ช๐ด ๐ด๐ฆ๐ฆ๐ฌ๐ช๐ฏ๐จ ๐ฆ๐ข๐ณ๐ญ๐บ ๐ข๐ค๐ค๐ฆ๐ด๐ด ๐ข๐ฑ๐ฑ๐ณ๐ฐ๐ท๐ข๐ญ๐ด ๐ช๐ฏ ๐ฐ๐ต๐ฉ๐ฆ๐ณ ๐ซ๐ถ๐ณ๐ช๐ด๐ฅ๐ช๐ค๐ต๐ช๐ฐ๐ฏ๐ด, ๐ข๐ฏ๐ต๐ช๐ค๐ช๐ฑ๐ข๐ต๐ช๐ฏ๐จ ๐ช๐ฏ๐ช๐ต๐ช๐ข๐ญ ๐ด๐ข๐ญ๐ฆ๐ด ๐ข๐ฏ๐ฅ ๐ค๐ญ๐ช๐ฏ๐ช๐ค๐ข๐ญ ๐ถ๐ด๐ฆ ๐ฐ๐ง ๐๐๐๐๐๐๐ ๐ธ๐ช๐ต๐ฉ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ค๐ฐ๐ฎ๐ช๐ฏ๐จ ๐บ๐ฆ๐ข๐ณ.”
LTR Pharma has made exceptional progress since its ASX debut at the end of 2023, having completed a pivotal clinical study demonstrating that SPONTAN is 470% faster absorption than oral vardenafil tablets. SPONTAN is now being prescribed to eligible patients in Australia under the TGAโs Special Access Scheme.